Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGIntron + Ribavirin in Chronic Hepatitis C Non-Responders
NCT00215865Phase 3Completed
- Sponsor
- Hepatitis Resource Network
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b in hepatitis C (HCV), sponsored by Hepatitis Resource Network. Status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00215865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215865.